Immucell (ICCC) Work In Process (2018 - 2026)

Immucell (ICCC) has reported Work In Process for 9 consecutive years, with $5.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Work In Process fell 0.75% year-over-year to $5.5 million; the trailing twelve-month figure through Jun 2026 stood at $5.5 million (down 0.75% YoY), and the FY2025 full-year result was $5.7 million, changed 0.04% from the prior year.
• Work In Process declined to $5.5 million in Q2 2026 per ICCC's latest filing, from $5.7 million in the prior quarter.
• Across five years, Work In Process topped out at $6.1 million in Q3 2024 and bottomed at $3.5 million in Q4 2022.
• Historically, Work In Process has averaged $5.5 million across 5 years, with a median of $5.6 million in 2024.
• The sharpest annual moves came in 2023 and 2025: Work In Process surged 67.65% in 2023, then dropped 2.81% in 2025.
• Over 5 years, Work In Process stood at $3.5 million in 2022, then surged by 67.65% to $5.8 million in 2023, then slipped by 1.18% to $5.7 million in 2024, then climbed by 0.04% to $5.7 million in 2025, then declined by 3.62% to $5.5 million in 2026.
• According to Business Quant data, Work In Process over the past three periods registered $5.5 million, $5.7 million, and $6.0 million for Q2 2026, Q4 2025, and Q3 2025 respectively.